Annual EBIT
-$170.19 M
+$287.31 M+62.80%
31 December 2023
Summary:
GeneDx Holdings annual earnings before interest & taxes is currently -$170.19 million, with the most recent change of +$287.31 million (+62.80%) on 31 December 2023. During the last 3 years, it has risen by +$68.67 million (+28.75%). WGS annual EBIT is now -488.48% below its all-time high of -$22.51 million.WGS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$7.78 M
+$20.69 M+72.67%
30 September 2024
Summary:
GeneDx Holdings quarterly earnings before interest & taxes is currently -$7.78 million, with the most recent change of +$20.69 million (+72.67%) on 30 September 2024. Over the past year, it has increased by +$26.91 million (+77.57%). WGS quarterly EBIT is now -123.28% below its all-time high of $33.41 million, reached on 01 September 2021.WGS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$81.62 M
+$26.91 M+24.79%
30 September 2024
Summary:
GeneDx Holdings TTM earnings before interest & taxes is currently -$81.62 million, with the most recent change of +$26.91 million (+24.79%) on 30 September 2024. Over the past year, it has increased by +$180.53 million (+68.87%). WGS TTM EBIT is now -45.80% below its all-time high of -$55.98 million, reached on 01 September 2020.WGS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WGS EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.8% | +77.6% | +68.9% |
| 3 y3 years | +28.8% | -123.3% | +75.1% |
| 5 y5 years | - | - | - |
WGS EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +62.8% | -123.3% | +94.2% | at high | +80.4% |
| 5 y | 5 years | -488.5% | +62.8% | -123.3% | +95.9% | -45.8% | +80.5% |
| alltime | all time | -488.5% | +62.8% | -123.3% | +95.9% | -45.8% | +80.5% |
GeneDx Holdings EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.78 M(-72.7%) | -$81.62 M(-24.8%) |
| June 2024 | - | -$28.47 M(+44.3%) | -$108.52 M(-17.6%) |
| Mar 2024 | - | -$19.72 M(-23.1%) | -$131.67 M(-23.9%) |
| Dec 2023 | -$170.19 M(-62.8%) | -$25.64 M(-26.1%) | -$173.05 M(-34.0%) |
| Sept 2023 | - | -$34.69 M(-32.8%) | -$262.14 M(-17.6%) |
| June 2023 | - | -$51.62 M(-15.5%) | -$318.28 M(-20.6%) |
| Mar 2023 | - | -$61.10 M(-46.7%) | -$400.68 M(-3.6%) |
| Dec 2022 | -$457.51 M | -$114.74 M(+26.3%) | -$415.67 M(+22.1%) |
| Sept 2022 | - | -$90.82 M(-32.2%) | -$340.41 M(+57.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$134.03 M(+76.1%) | -$216.18 M(+69.4%) |
| Mar 2022 | - | -$76.09 M(+92.7%) | -$127.59 M(-47.4%) |
| Dec 2021 | -$242.56 M(+1.5%) | - | - |
| Dec 2021 | - | -$39.48 M(-218.1%) | -$242.56 M(-26.1%) |
| Sept 2021 | - | $33.41 M(-173.5%) | -$328.11 M(-21.4%) |
| June 2021 | - | -$45.44 M(-76.2%) | -$417.50 M(+12.2%) |
| Mar 2021 | - | -$191.05 M(+52.8%) | -$372.06 M(+105.5%) |
| Dec 2020 | -$238.87 M(+725.9%) | -$125.03 M(+123.4%) | -$181.01 M(+223.4%) |
| Sept 2020 | - | -$55.98 M | -$55.98 M |
| Dec 2019 | -$28.92 M | - | - |
FAQ
- What is GeneDx Holdings annual earnings before interest & taxes?
- What is the all time high annual EBIT for GeneDx Holdings?
- What is GeneDx Holdings annual EBIT year-on-year change?
- What is GeneDx Holdings quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for GeneDx Holdings?
- What is GeneDx Holdings quarterly EBIT year-on-year change?
- What is GeneDx Holdings TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for GeneDx Holdings?
- What is GeneDx Holdings TTM EBIT year-on-year change?
What is GeneDx Holdings annual earnings before interest & taxes?
The current annual EBIT of WGS is -$170.19 M
What is the all time high annual EBIT for GeneDx Holdings?
GeneDx Holdings all-time high annual earnings before interest & taxes is -$22.51 M
What is GeneDx Holdings annual EBIT year-on-year change?
Over the past year, WGS annual earnings before interest & taxes has changed by +$287.31 M (+62.80%)
What is GeneDx Holdings quarterly earnings before interest & taxes?
The current quarterly EBIT of WGS is -$7.78 M
What is the all time high quarterly EBIT for GeneDx Holdings?
GeneDx Holdings all-time high quarterly earnings before interest & taxes is $33.41 M
What is GeneDx Holdings quarterly EBIT year-on-year change?
Over the past year, WGS quarterly earnings before interest & taxes has changed by +$26.91 M (+77.57%)
What is GeneDx Holdings TTM earnings before interest & taxes?
The current TTM EBIT of WGS is -$81.62 M
What is the all time high TTM EBIT for GeneDx Holdings?
GeneDx Holdings all-time high TTM earnings before interest & taxes is -$55.98 M
What is GeneDx Holdings TTM EBIT year-on-year change?
Over the past year, WGS TTM earnings before interest & taxes has changed by +$180.53 M (+68.87%)